- Home
- FNGR vs ASRT Comparison
FNGR vs ASRT Comparison
Compare FNGR & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNGR
- ASRT
- Stock Information
- Founded
- FNGR 2016
- ASRT 1995
- Country
- FNGR Singapore
- ASRT United States
- Employees
- FNGR N/A
- ASRT N/A
- Industry
- FNGR Computer Software: Prepackaged Software
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- FNGR Technology
- ASRT Health Care
- Exchange
- FNGR Nasdaq
- ASRT Nasdaq
- Market Cap
- FNGR 87.9M
- ASRT 79.1M
- IPO Year
- FNGR N/A
- ASRT 1997
- Fundamental
- Price
- FNGR $1.62
- ASRT $0.79
- Analyst Decision
- FNGR
- ASRT Strong Buy
- Analyst Count
- FNGR 0
- ASRT 1
- Target Price
- FNGR N/A
- ASRT $3.00
- AVG Volume (30 Days)
- FNGR 397.1K
- ASRT 249.4K
- Earning Date
- FNGR 10-14-2025
- ASRT 08-11-2025
- Dividend Yield
- FNGR N/A
- ASRT N/A
- EPS Growth
- FNGR N/A
- ASRT N/A
- EPS
- FNGR N/A
- ASRT N/A
- Revenue
- FNGR $35,692,374.00
- ASRT $117,099,000.00
- Revenue This Year
- FNGR N/A
- ASRT N/A
- Revenue Next Year
- FNGR N/A
- ASRT $5.84
- P/E Ratio
- FNGR N/A
- ASRT N/A
- Revenue Growth
- FNGR 11.55
- ASRT N/A
- 52 Week Low
- FNGR $1.03
- ASRT $0.51
- 52 Week High
- FNGR $5.20
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- FNGR 49.08
- ASRT 58.21
- Support Level
- FNGR $1.50
- ASRT $0.71
- Resistance Level
- FNGR $1.65
- ASRT $0.86
- Average True Range (ATR)
- FNGR 0.09
- ASRT 0.03
- MACD
- FNGR 0.04
- ASRT -0.00
- Stochastic Oscillator
- FNGR 85.25
- ASRT 50.53
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.